Výsledky vyhledávání - "M. M. Makhinova"

Akademický článek

Clinical efficacy of a personalized exercise program in the rehabilitation of patients with atrial fibrillation after radiofrequency ablation

Autor: M. G. Bubnova, D. M. Aronov, M. M. Makhinova, K. V. Davtyan

Publikováno v: Российский кардиологический журнал, Vol 27, Iss 7 (2022)

Aim. To study the clinical efficacy and safety of a personalized exercise program in the rehabilitation of patients with paroxysmal atrial fibrillation (AF) after primary pulmonary vein radiofrequency ablation (RFA).Material and methods. Patients (n=

Externí odkaz: https://doaj.org/article/d269437132e04093b58274a154228ac1

Zobrazit plný text záznamu

Akademický článek

COMPARATIVE PHARMACOKINETICS AND EFFECT ON THE HEMODYNAMICS OF ORIGINAL AND GENERIC NEBIVOLOL IN HEALTHY VOLUNTEERS

Autor: E. I. Bambysheva, K. V. Isaeva, M. M. Makhinova, D. T. Guranda, V. G. Belolipetskaya

Publikováno v: Рациональная фармакотерапия в кардиологии, Vol 12, Iss 2, Pp 171-175 (2016)

Beta-blockers are an important part of modern pharmacotherapy in cardiology. The introduction of generics into clinical practice requires clear evidence of bioequivalence to the original drug.Aim. To study the pharmacokinetics and effect on hemodynam

Externí odkaz: https://doaj.org/article/aaba2de1f7ce4ae9a94fd50d8a0ff38b

Zobrazit plný text záznamu

Akademický článek

Radiofrequency ablation and antiarrhythmic therapy in the treatment of patients with paroxysmal and persistent atrial fibrillation: clinical effects

Autor: M. G Bubnova, D. M Aronov, M. M Makhinova

Publikováno v: КардиоСоматика, Vol 6, Iss 3, Pp 38-47 (2015)

The purpose of this article is to discuss the issues related to the treatment of patients with paroxysmal and persistent atrial fibrillation (AF). The article discusses the indications for patients with radiofrequency catheter (RFC) ablation of the m

Externí odkaz: https://doaj.org/article/98b2800649e442d085f87a84aea66914

Zobrazit plný text záznamu

Akademický článek

Results of propafenone use in early postoperative period after pulmonary veins catheter radiofrequency isolation for prevention of early atrial tachyarrhythmias

Autor: A. V Tarasov, K. V Davtian, M. M Makhinova

Publikováno v: КардиоСоматика, Vol 6, Iss 2, Pp 47-52 (2015)

Currently pulmonary veins isolation becomes one of the approaches for invasive treatment of paroxysmal atrial fibrillation (AF). One of difficult and unexplored problems associated with this procedure is management of patients in postoperative period

Externí odkaz: https://doaj.org/article/5bb3f71a80d44982b213930935d768ef

Zobrazit plný text záznamu

Akademický článek

Klinicheskie effekty programmy fizicheskoy reabilitatsii posle radiochastotnoy kateternoy ablatsii u bol'nykh s paroksizmal'noy formoy fibrillyatsii predserdiy

Autor: M. G Bubnova, D. M Aronov, M. M Makhinova, N. K Novikova

Publikováno v: КардиоСоматика, Vol 8, Iss 1, Pp 17-18 (2017)

Цель. Изучить влияние персонализированной программы физической реабилитации на показатели физической активности (ФА) и психологическо

Externí odkaz: https://doaj.org/article/2c677adcc8e44ab788d7e1995763ecfc

Zobrazit plný text záznamu

Akademický článek

Osobennosti psikhologicheskogo statusa i kachestva zhizni bol'nykh s fibrillyatsiey predserdiy posle radiochastotnoy izolyatsii ust'ev legochnykh ven

Autor: M. M Makhinova, M. G Bubnova, K. V Davtyan

Publikováno v: КардиоСоматика, Vol 6, Iss 1-1, Pp 66-67 (2015)

Фибрилляция предсердий (ФП) - одна из часто встречаемых форм нарушений ритма сердца. Наличие пароксизмов ФП у пациентов значительно сниж

Externí odkaz: https://doaj.org/article/ec0aa91d8c9a4c98b82745d095eb1069

Zobrazit plný text záznamu

COMPARATIVE PHARMACOKINETICS AND EFFECT ON THE HEMODYNAMICS OF ORIGINAL AND GENERIC NEBIVOLOL IN HEALTHY VOLUNTEERS

Autor: M. M. Makhinova, E. I. Bambysheva, V. G. Belolipetskaya, D. T. Guranda, K. V. Isaeva

Publikováno v: Racionalʹnaâ Farmakoterapiâ v Kardiologii, Vol 12, Iss 2, Pp 171-175 (2016)

Beta-blockers are an important part of modern pharmacotherapy in cardiology. The introduction of generics into clinical practice requires clear evidence of bioequivalence to the original drug. Aim. To study the pharmacokinetics and effect on hemodyna

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b644e39a375ab5598249a2ad152a0c7f
https://www.rpcardio.com/jour/article/view/1234

Zobrazit plný text záznamu